Standard

Regional aspects of the gene polymorphism VEGFR2 with coronary atherosclerosis in acute coronary syndrome. / Nikolaev, K. Yu; Urvantseva, I. A.; Batueva, K. Yu et al.

In: Russian Journal of Cardiology, Vol. 150, No. 10, 01.01.2017, p. 61-65.

Research output: Contribution to journalArticlepeer-review

Harvard

Nikolaev, KY, Urvantseva, IA, Batueva, KY, Apartsin, KA, Gorokhova, AV, Ganyukov, VI, Kochergin, NA, Zelenskaya, EM & Lifshits, GI 2017, 'Regional aspects of the gene polymorphism VEGFR2 with coronary atherosclerosis in acute coronary syndrome', Russian Journal of Cardiology, vol. 150, no. 10, pp. 61-65. https://doi.org/10.15829/1560-4071-2017-10-61-65

APA

Nikolaev, K. Y., Urvantseva, I. A., Batueva, K. Y., Apartsin, K. A., Gorokhova, A. V., Ganyukov, V. I., Kochergin, N. A., Zelenskaya, E. M., & Lifshits, G. I. (2017). Regional aspects of the gene polymorphism VEGFR2 with coronary atherosclerosis in acute coronary syndrome. Russian Journal of Cardiology, 150(10), 61-65. https://doi.org/10.15829/1560-4071-2017-10-61-65

Vancouver

Nikolaev KY, Urvantseva IA, Batueva KY, Apartsin KA, Gorokhova AV, Ganyukov VI et al. Regional aspects of the gene polymorphism VEGFR2 with coronary atherosclerosis in acute coronary syndrome. Russian Journal of Cardiology. 2017 Jan 1;150(10):61-65. doi: 10.15829/1560-4071-2017-10-61-65

Author

Nikolaev, K. Yu ; Urvantseva, I. A. ; Batueva, K. Yu et al. / Regional aspects of the gene polymorphism VEGFR2 with coronary atherosclerosis in acute coronary syndrome. In: Russian Journal of Cardiology. 2017 ; Vol. 150, No. 10. pp. 61-65.

BibTeX

@article{784894d2e7544ce39b415f1def3da119,
title = "Regional aspects of the gene polymorphism VEGFR2 with coronary atherosclerosis in acute coronary syndrome",
abstract = "Aim. Evaluation of the associations of allele variant of gene VEGFR2 rs2305948 with atherosclerotic lesion of coronary arteries in acute coronary syndrome (ACS) patients in the North (Surgut city) and big cities of the Siberian Federal District (SFD) (Novosibirsk, Irkutsk, Kemerovo). Material and methods. Totally, 258 consecutive ACS patients investigated, at admission to cardiological in-patient clinics of big cities of the North (Surgut, 78 patients) and SFD (180 patients). All patients underwent coronary arteriography and genetic test (the allele variant assessment VEGFR2 rs2305948). Results. In Surgut patients the allele variant VEGFR2*CC is directly linked with the lesion of proximal and intermediate part of three main arteries >70% (PTA) (χ2 = 4,68; p=0,031), PTA and left main stem stenosis >50% (χ2 = 7,02; p=0,008), and in patients from SFD VEGFR2 *CT + *TT is directly associated with hypercholesterolemia (HC) (χ2 = 8,53; p=0,003). Combination of allele variant VEGFR2*CC with HC directly influences PTA of stem stenosis >50% in ACS patients in Surgut (Exp (B) =4,441; 95% CI (1,351; 14,601); p=0,014). Combination of allele variant VEGFR2*CC with HC directly influences stenosis >70% existence in at least three coronary arteries, in Surgut patients (Exp (B): 3,697; 95% CI (1,304; 10,486); p=0,014), as in SFD patients Exp (B): 4,460; 95% CI (1,306; 15,236); p=0,017). Conclusion. Allele variant VEGFR2*CC does directly influence the existence of coronary atherosclerosis of various grade severity in patients with ACS in the North, and if combined with VEGFR2*CC and HC is also a risk factor for coronary atherosclerosis not only in the North but in SFD cities as well.",
keywords = "Acute coronary syndrome, Allele variants of VEGFR2, Coronary atherosclerosis, Hypercholesterolemia, The North",
author = "Nikolaev, {K. Yu} and Urvantseva, {I. A.} and Batueva, {K. Yu} and Apartsin, {K. A.} and Gorokhova, {A. V.} and Ganyukov, {V. I.} and Kochergin, {N. A.} and Zelenskaya, {E. M.} and Lifshits, {G. I.}",
year = "2017",
month = jan,
day = "1",
doi = "10.15829/1560-4071-2017-10-61-65",
language = "English",
volume = "150",
pages = "61--65",
journal = "Российский кардиологический журнал",
issn = "1560-4071",
publisher = "Russian Society of Cardiology",
number = "10",

}

RIS

TY - JOUR

T1 - Regional aspects of the gene polymorphism VEGFR2 with coronary atherosclerosis in acute coronary syndrome

AU - Nikolaev, K. Yu

AU - Urvantseva, I. A.

AU - Batueva, K. Yu

AU - Apartsin, K. A.

AU - Gorokhova, A. V.

AU - Ganyukov, V. I.

AU - Kochergin, N. A.

AU - Zelenskaya, E. M.

AU - Lifshits, G. I.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Aim. Evaluation of the associations of allele variant of gene VEGFR2 rs2305948 with atherosclerotic lesion of coronary arteries in acute coronary syndrome (ACS) patients in the North (Surgut city) and big cities of the Siberian Federal District (SFD) (Novosibirsk, Irkutsk, Kemerovo). Material and methods. Totally, 258 consecutive ACS patients investigated, at admission to cardiological in-patient clinics of big cities of the North (Surgut, 78 patients) and SFD (180 patients). All patients underwent coronary arteriography and genetic test (the allele variant assessment VEGFR2 rs2305948). Results. In Surgut patients the allele variant VEGFR2*CC is directly linked with the lesion of proximal and intermediate part of three main arteries >70% (PTA) (χ2 = 4,68; p=0,031), PTA and left main stem stenosis >50% (χ2 = 7,02; p=0,008), and in patients from SFD VEGFR2 *CT + *TT is directly associated with hypercholesterolemia (HC) (χ2 = 8,53; p=0,003). Combination of allele variant VEGFR2*CC with HC directly influences PTA of stem stenosis >50% in ACS patients in Surgut (Exp (B) =4,441; 95% CI (1,351; 14,601); p=0,014). Combination of allele variant VEGFR2*CC with HC directly influences stenosis >70% existence in at least three coronary arteries, in Surgut patients (Exp (B): 3,697; 95% CI (1,304; 10,486); p=0,014), as in SFD patients Exp (B): 4,460; 95% CI (1,306; 15,236); p=0,017). Conclusion. Allele variant VEGFR2*CC does directly influence the existence of coronary atherosclerosis of various grade severity in patients with ACS in the North, and if combined with VEGFR2*CC and HC is also a risk factor for coronary atherosclerosis not only in the North but in SFD cities as well.

AB - Aim. Evaluation of the associations of allele variant of gene VEGFR2 rs2305948 with atherosclerotic lesion of coronary arteries in acute coronary syndrome (ACS) patients in the North (Surgut city) and big cities of the Siberian Federal District (SFD) (Novosibirsk, Irkutsk, Kemerovo). Material and methods. Totally, 258 consecutive ACS patients investigated, at admission to cardiological in-patient clinics of big cities of the North (Surgut, 78 patients) and SFD (180 patients). All patients underwent coronary arteriography and genetic test (the allele variant assessment VEGFR2 rs2305948). Results. In Surgut patients the allele variant VEGFR2*CC is directly linked with the lesion of proximal and intermediate part of three main arteries >70% (PTA) (χ2 = 4,68; p=0,031), PTA and left main stem stenosis >50% (χ2 = 7,02; p=0,008), and in patients from SFD VEGFR2 *CT + *TT is directly associated with hypercholesterolemia (HC) (χ2 = 8,53; p=0,003). Combination of allele variant VEGFR2*CC with HC directly influences PTA of stem stenosis >50% in ACS patients in Surgut (Exp (B) =4,441; 95% CI (1,351; 14,601); p=0,014). Combination of allele variant VEGFR2*CC with HC directly influences stenosis >70% existence in at least three coronary arteries, in Surgut patients (Exp (B): 3,697; 95% CI (1,304; 10,486); p=0,014), as in SFD patients Exp (B): 4,460; 95% CI (1,306; 15,236); p=0,017). Conclusion. Allele variant VEGFR2*CC does directly influence the existence of coronary atherosclerosis of various grade severity in patients with ACS in the North, and if combined with VEGFR2*CC and HC is also a risk factor for coronary atherosclerosis not only in the North but in SFD cities as well.

KW - Acute coronary syndrome

KW - Allele variants of VEGFR2

KW - Coronary atherosclerosis

KW - Hypercholesterolemia

KW - The North

UR - http://www.scopus.com/inward/record.url?scp=85035023567&partnerID=8YFLogxK

U2 - 10.15829/1560-4071-2017-10-61-65

DO - 10.15829/1560-4071-2017-10-61-65

M3 - Article

AN - SCOPUS:85035023567

VL - 150

SP - 61

EP - 65

JO - Российский кардиологический журнал

JF - Российский кардиологический журнал

SN - 1560-4071

IS - 10

ER -

ID: 10066028